Abstract
Ultrasonic energy has been proven that at suitable frequency range (670-kHz to 2-MHz), ultrasound can be focused to a specific target, and the concentrated energy has sufficient high acoustic pressure so as that capable of inducing localized blood-brain barrier (BBB) disruption, which has a important implication on noninvasively delivering drug into brain.
Translated title of the contribution | NONINVASIVELY LOW-FREQUENCY ULTRASONIC APPARATUS FOR THE BRAIN THERAPY |
---|---|
Original language | Chinese (Traditional) |
IPC | A61N-007/00(2006.01) |
State | Published - 16 01 2010 |
Bibliographical note
公開公告號: 2.01002381E8Announcement ID: 2.01002381E8